Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Sep;72(3):788–791. doi: 10.1038/bjc.1995.412

Urinary nicotine metabolite excretion and lung cancer risk in a female cohort.

G A Ellard 1, F de Waard 1, J M Kemmeren 1
PMCID: PMC2033895  PMID: 7669596

Abstract

A nested lung cancer case-control study was carried out using 397 12 h urine samples originally collected from a cohort of over 26,000 women aged 40-64 at entry who were then followed for up to 15 years. The urine samples from active smokers were first identified using a simple qualitative method and their total nicotine metabolites/creatinine ratios then determined by automated colorimetric methods. The results obtained demonstrated the capacity of nicotine metabolite estimations in a single 12 h sample of urine to predict the subsequent risk of lung cancer. The risk of lung cancer among the biochemically proven active smokers during this period was 7.8 times that of the non-smokers, suggesting that the dose-response relationship between smoking and lung cancer is no less step in women than in men. The smoking-related risk of adenocarcinoma was less than that of other lung carcinomas. It is suggested that this biochemical epidemiology approach to exploring the relationship between smoking and lung cancer could profitably be applied to the study of other smoking-related diseases.

Full text

PDF
788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage A. K., Alexander J., Hopkins R., Ward C. Evaluation of a low to middle tar/medium nicotine cigarette designed to maintain nicotine delivery to the smoker. Psychopharmacology (Berl) 1988;96(4):447–453. doi: 10.1007/BF02180022. [DOI] [PubMed] [Google Scholar]
  2. Barlow R. D., Stone R. B., Wald N. J., Puhakainen E. V. The direct barbituric acid assay for nicotine metabolites in urine: a simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake. Clin Chim Acta. 1987 May 29;165(1):45–52. doi: 10.1016/0009-8981(87)90217-8. [DOI] [PubMed] [Google Scholar]
  3. Benowitz N. L., Hall S. M., Herning R. I., Jacob P., 3rd, Jones R. T., Osman A. L. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983 Jul 21;309(3):139–142. doi: 10.1056/NEJM198307213090303. [DOI] [PubMed] [Google Scholar]
  4. Benowitz N. L., Jacob P., 3rd Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther. 1984 Apr;35(4):499–504. doi: 10.1038/clpt.1984.67. [DOI] [PubMed] [Google Scholar]
  5. Benowitz N. L., Jacob P., 3rd, Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 1994 Jan;268(1):296–303. [PubMed] [Google Scholar]
  6. Byrd G. D., Chang K. M., Greene J. M., deBethizy J. D. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Drug Metab Dispos. 1992 Mar-Apr;20(2):192–197. [PubMed] [Google Scholar]
  7. Garfinkel L., Stellman S. D. Smoking and lung cancer in women: findings in a prospective study. Cancer Res. 1988 Dec 1;48(23):6951–6955. [PubMed] [Google Scholar]
  8. Hill P., Haley N. J., Wynder E. L. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis. 1983;36(6):439–449. doi: 10.1016/0021-9681(83)90136-4. [DOI] [PubMed] [Google Scholar]
  9. Jarvis M. J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987 Nov;77(11):1435–1438. doi: 10.2105/ajph.77.11.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jarvis M., Tunstall-Pedoe H., Feyerabend C., Vesey C., Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984 Dec;38(4):335–339. doi: 10.1136/jech.38.4.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Peach H., Ellard G. A., Jenner P. J., Morris R. W. A simple, inexpensive urine test of smoking. Thorax. 1985 May;40(5):351–357. doi: 10.1136/thx.40.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Phillips G. F., Waller R. E. Yields of tar and other smoke components from UK cigarettes. Food Chem Toxicol. 1991 Jul;29(7):469–474. doi: 10.1016/0278-6915(91)90093-m. [DOI] [PubMed] [Google Scholar]
  13. Puhakainen E. V., Barlow R. D., Salonen J. T. An automated colorimetric assay for urine nicotine metabolites: a suitable alternative to cotinine assays for the assessment of smoking status. Clin Chim Acta. 1987 Dec;170(2-3):255–262. doi: 10.1016/0009-8981(87)90135-5. [DOI] [PubMed] [Google Scholar]
  14. Russell M. A., Jarvis M. J., Feyerabend C., Saloojee Y. Reduction of tar, nicotine and carbon monoxide intake in low tar smokers. J Epidemiol Community Health. 1986 Mar;40(1):80–85. doi: 10.1136/jech.40.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wald N. J., Boreham J., Bailey A., Ritchie C., Haddow J. E., Knight G. Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet. 1984 Jan 28;1(8370):230–231. doi: 10.1016/s0140-6736(84)92156-1. [DOI] [PubMed] [Google Scholar]
  16. Wall M. A., Johnson J., Jacob P., Benowitz N. L. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health. 1988 Jun;78(6):699–701. doi: 10.2105/ajph.78.6.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Withey C. H., Papacosta A. O., Swan A. V., Fitzsimons B. A., Ellard G. A., Burney P. G., Colley J. R., Holland W. W. Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II. Results of a randomised controlled trial. J Epidemiol Community Health. 1992 Jun;46(3):281–285. doi: 10.1136/jech.46.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Woodward M., Tunstall-Pedoe H., Smith W. C., Tavendale R. Smoking characteristics and inhalation biochemistry in the Scottish population. J Clin Epidemiol. 1991;44(12):1405–1410. doi: 10.1016/0895-4356(91)90101-e. [DOI] [PubMed] [Google Scholar]
  19. de Waard F., Kemmeren J. M., van Ginkel L. A., Stolker A. A. Urinary cotinine and lung cancer risk in a female cohort. Br J Cancer. 1995 Sep;72(3):784–787. doi: 10.1038/bjc.1995.411. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES